Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
198.92B
Market cap198.92B
Price-Earnings ratio
10.38
Price-Earnings ratio10.38
Dividend yield
2.78%
Dividend yield2.78%
Average volume
15.67M
Average volume15.67M
High today
$44.84
High today$44.84
Low today
$43.83
Low today$43.83
Open price
$44.37
Open price$44.37
Volume
9.70M
Volume9.70M
52 Week high
$81.44
52 Week high$81.44
52 Week low
$35.12
52 Week low$35.12

NVO News

Simply Wall St 2h
Wegovy Liver Data Broadens Semaglutide Story For Novo Nordisk Investors

Novo Nordisk (NYSE:NVO) reported new semaglutide (Wegovy) data at the EASL 2026 congress on liver safety and efficacy in chronic liver disease. The trials focu...

Wegovy Liver Data Broadens Semaglutide Story For Novo Nordisk Investors
TipRanks 9h
Novo Nordisk Advances New Cagrilintide Study in the Race for Obesity Leadership

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decision...

TipRanks 9h
Novo Nordisk’s AMAZE 2 Trial: A New Weight-Loss Shot Targets Growth Beyond Semaglutide

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decision...

Analyst ratings

58%

of 36 ratings
Buy
33.3%
Hold
58.3%
Sell
8.3%

More NVO News

Nasdaq 1d
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss Party

Key Points There is a need for more weight loss drug options, including oral pills. Viking Therapeutics is working on a promising one, though tolerability mig...

Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss Party
The Motley Fool 1d
Eli Lilly Stock: Next Stop $2,000?

It's been a volatile year for Eli Lilly (LLY 1.61%). The company's shares trended lower through the end of April, dropping well below $900. However, the drugmak...

Eli Lilly Stock: Next Stop $2,000?
24/7 Wall St. 1d
Three Biotechs That Are Top Takeover Targets

Three Biotechs That Are Top Takeover Targets By Alex Sirois Published May 18, 1:55PM EDT Quick Read Viking Therapeutics (VKTX) has a dual GLP-1/GIP agonist in...

Three Biotechs That Are Top Takeover Targets
TipRanks 1d
Novo Nordisk Details Progress on DKK 15 Billion Share Buyback Programme

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 4d
Novo Nordisk Expands Obesity Pipeline With AMAZE 6 Knee Osteoarthritis Trial

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decision...

TipRanks 4d
Mixed options sentiment in Novo Nordisk with shares down 2.61%

Mixed options sentiment in Novo Nordisk (NVO), with shares down $1.20 near $44.60. Options volume relatively light with 26k contracts traded and calls leading p...

Nasdaq 4d
Buy, Sell, or Hold Novo Nordisk at $46?

Key Points The bulk of Novo Nordisk's sales come from weight-loss and diabetes treatments. The biotech faces competition from companies like Eli Lilly and Pfi...

Buy, Sell, or Hold Novo Nordisk at $46?

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.